Biogen and Eisai’s monoclonal antibody drugs for Alzheimer’s — Aduhelm (now off the market) and Leqembi (fully approved by the FDA in 2023) —…
Experts estimate that, by 2023, nearly 40 percent of the more than eight million Americans living with Alzheimer’s and related dementias will be Latino…
About 14 of every 100 of Black Americans older than 65 have Alzheimer’s disease, compared 10 in 100 white Americans of the same age…
The process of finding new treatments for Alzheimer’s disease is one of trial and error — and every “failed” trial generates invaluable new data…
There are dozens of new approaches to treating Alzheimer’s currently in clinical trials. But while some promising innovations in diagnostics and intervention are progressing…
Alzheimer’s disease affects one in every three people over the age of 85, and the scale of the epidemic is only worsening. While there…
Over 55 million people worldwide have dementia. This mind-robbing condition has a huge impact on society and the economy, so scientists are working hard…
Have you heard of Wegovy, Ozempic, and Mounjaro? These new medications — that muffle hunger signals in the brain — are all the rage….
As Dr. Jeff Chen MD, MBA recalled in a recent talk at the 2023 TED Conference in Vancouver, BC, when he was a medical…
Since the United States imposed an embargo on Cuba in 1961, the island nation has built a robust healthcare system on their own, with…
After almost two decades of stagnation, two new drugs for Alzheimer’s have hit the market in the last three years. The approval of Biogen…
With research for the recently FDA-approved Leqembi still in clinical trials and other Alzheimer’s research ongoing, many are considering whether to be a part…
Eisai and Biogen’s new anti-amyloid drug Leqembi was recently approved through the FDA’s accelerated pathway. Now, it’s on the market with a price tag…
UPDATE: 3 March 2024, 8:16 P.M. ET. In February 2024, Biogen took Aduhelm off the market, citing financial concerns. Although the drug did receive…
The United States imposed a blockade against Cuba in 1961, and currently there isn’t much collaboration — or even, much communication — about medical…